We are live on ! Find out more
PIM

Partner Investment Management Portfolio holdings

AUM $13.9M
1-Year Est. Return 55.92%
This Fund
S&P 500
This Quarter Est. Return
+23.93%
1 Year Est. Return
+55.92%
3 Year Est. Return
+168.07%
5 Year Est. Return
+301.91%
10 Year Est. Return
–
AUM
$86.5M
AUM Growth
+$6.47M
Cap. Flow
-$1.87M
Cap. Flow %
-2.16%
Top 10 Hldgs %
33.2%
Holding
120
New
33
Increased
16
Reduced
36
Closed
30

Top Buys

Rank Stock Value
1
SYK icon
Stryker
SYK
+$2.09M
2
AGN
Allergan plc
AGN
+$1.67M
3
WCG
Wellcare Health Plans, Inc.
WCG
+$1.52M
4
PFE icon
Pfizer
PFE
+$1.42M
5
UNH icon
UnitedHealth
UNH
+$1.12M

Top Sells

Rank Stock Value
1
ALLK
Allakos
ALLK
+$4.3M
2
UBX
Unity Biotechnology
UBX
+$3.43M
3
NTGN
Neon Therapeutics, Inc. Common Stock
NTGN
+$2.48M
4
BLK icon
Blackrock
BLK
+$1.71M
5
GDDY icon
GoDaddy
GDDY
+$1.69M

Sector Composition

Rank Sector Weight
1 Healthcare 46.46%
2 Technology 17.92%
3 Communication Services 6.41%
4 Consumer Discretionary 5.03%
5 Financials 1.87%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
EXAS
51
DELISTED
Exact Sciences
EXAS
$616K 0.71%
+7,115
New +$606K
NVRO
52
DELISTED
NEVRO CORP.
NVRO
$575K 0.66%
9,192
+2,338
+34% +$110K
EW icon
53
CALL
Edwards Lifesciences
EW
$51.7B
$574K 0.66%
+9,000
New +$514K
TCOM icon
54
Trip.com Group
TCOM
$29.1B
$524K 0.61%
+11,999
New +$421K
TWLO icon
55
Twilio
TWLO
$36.6B
$492K 0.57%
3,810
-32
-0.8% -$3.6K
COUP
56
DELISTED
Coupa Software Incorporated
COUP
$492K 0.57%
5,411
-2,164
-29% -$185K
DATA
57
DELISTED
Tableau Software, Inc.
DATA
$489K 0.57%
3,839
-4,251
-53% -$537K
A icon
58
Agilent Technologies
A
$41.2B
$452K 0.52%
+5,623
New +$427K
ONCE
59
DELISTED
Spark Therapeutics, Inc. Common Stock
ONCE
$441K 0.51%
3,874
-22,603
-85% -$1.66M
IRTC icon
60
iRhythm Holdings
IRTC
$4.2B
$417K 0.48%
5,565
+884
+19% +$75.6K
PTCT icon
61
PTC Therapeutics
PTCT
$6.12B
$417K 0.48%
+11,083
New +$372K
PVTL
62
DELISTED
Pivotal Software, Inc.
PVTL
$385K 0.44%
18,464
-13,555
-42% -$265K
SPLK
63
DELISTED
Splunk Inc
SPLK
$355K 0.41%
+2,848
New +$356K
WMGI
64
DELISTED
Wright Medical Group Inc
WMGI
$348K 0.4%
11,057
-5,796
-34% -$176K
SAGE
65
DELISTED
Sage Therapeutics
SAGE
$340K 0.39%
2,138
-4,046
-65% -$586K
WVE icon
66
Wave Life Sciences
WVE
$1.2B
$287K 0.33%
+7,383
New +$300K
ALDR
67
DELISTED
Alder Biopharmaceuticals
ALDR
$235K 0.27%
+17,247
New +$223K
LYFT icon
68
Lyft
LYFT
$6.63B
$219K 0.25%
+2,792
New +$219K
DERM
69
DELISTED
Dermira, Inc.
DERM
$207K 0.24%
+15,257
New +$127K
QURE icon
70
uniQure
QURE
$3.22B
$203K 0.23%
+3,411
New +$152K
LAB icon
71
Standard BioTools
LAB
$314M
$194K 0.22%
+14,624
New +$154K
VYGR icon
72
Voyager Therapeutics
VYGR
$201M
$194K 0.22%
+10,136
New +$132K
CSII
73
DELISTED
Cardiovascular Systems, Inc.
CSII
$173K 0.2%
4,470
-10,104
-69% -$342K
FATE icon
74
Fate Therapeutics
FATE
$326M
$138K 0.16%
7,872
-4,415
-36% -$69.7K
SHOP icon
75
Shopify
SHOP
$195B
$128K 0.15%
+6,200
New +$109K
1 2
3
4 5

Similar funds

SWM
Sequoia Wealth Management Hoffman Estates, Illinois $12.9M AUM 25.75% 1-Year Est. Return
ACM
ADI Capital Management New York $17.5M AUM 49.32% 1-Year Est. Return
ECAU
Everett Capital Advisors (UK) London, United Kingdom $18.6M AUM 22.81% 1-Year Est. Return
SL
Signition LP New York $20M AUM 28.26% 1-Year Est. Return
DII
Domini Impact Investments New York $7.59M AUM 47.68% 1-Year Est. Return
FIM
FourPoints Investment Managers Paris, France $21.1M AUM 11.11% 1-Year Est. Return
EM
Emancipation Management New York $22.4M AUM 18.33% 1-Year Est. Return
BHC
Balch Hill Capital San Francisco, California $22.8M AUM

Partner Investment Management's Q1 2019 Portfolio in Review

As of Q1 2019, Partner Investment Management held 120 positions worth $86.5M, up 8.1% from $80.1M the previous quarter. Its ten largest holdings account for 33% of the portfolio.

Partner Investment Management's Q1 2019 filing shows 33 new, 16 increased, 36 reduced and 30 closed positions. Its largest new stake was Stryker: 11,607 shares worth $2.29M. The largest sale was Allakos, an estimated $4.3M.

By sector, the portfolio is most concentrated in Healthcare at 46% of assets, down from 54% a quarter earlier, followed by Technology and Communication Services.

  • Partner Investment Management's largest Q1 2019 buy was Stryker: 11,607 shares worth $2.29M.
  • Partner Investment Management added most to Pfizer in Q1 2019, an estimated $1.42M increase.
  • Partner Investment Management's biggest Q1 2019 reduction was Unity Biotechnology, cutting an estimated $3.43M.
  • Partner Investment Management fully exited Allakos in Q1 2019, selling an estimated $4.3M.
  • Partner Investment Management's ten largest holdings make up 33% of its $86.5M portfolio in Q1 2019.
  • Partner Investment Management opened 33 new positions and closed 30 in Q1 2019.
  • Partner Investment Management's portfolio value rose 8.1% quarter-over-quarter to $86.5M.

Based on Partner Investment Management's 13F filing for Q1 2019, filed 15 May 2019.